Enhanced Transport Capabilities via Nanotechnologies: Impacting Bioefficacy, Controlled Release Strategies, and Novel Chaperones
Journal of Drug Delivery · 26.04.2011 · 2011 · 1-14
DOI: 10.1155/2011/902403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery, erschienen am 26.04.2011. Verfasst von Thomai Panagiotou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Microfluidics International Corporation, P.O. Box 9101, Newton, MA 02464, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Emerging nanotechnologies have, and will continue to have, a major impact on the pharmaceutical industry. Their influence on a drug's life cycle, inception to delivery, is rapidly expanding. As the industry moves more aggressively toward continuous manufacturing modes, utilizing Process Analytical Technology (PAT) and Process Intensification (PI) concepts, the critical role of transport phenomena becomes elucidated. The ability to transfer energy, mass, and momentum with directed purposeful outcomes is a worthwhile endeavor in establishing higher production rates more economically. Furthermore, the ability to obtain desired drug properties, such as size, habit, and morphology, through novel manufacturing strategies permits unique formulation control for optimum delivery methodologies. Bottom-up processing to obtain nano-sized crystals is an excellent example. Formulation and delivery are intimately coupled in improving bio-efficacy at reduced loading and/or better controlled release capabilities, minimizing side affects and providing improved therapeutic interventions. Innovative nanotechnology applications, such as simultaneous targeting, imaging and delivery to tumors, are now possible through use of novel chaperones. Other examples include nanoparticles attachment to T-cells, release from novel hydrogel implants, and functionalized encapsulants. Difficult tasks such as drug delivery to the brain via the blood brain barrier and/or the cerebrospinal fluid are now easier to accomplish.
Autor:innen und Institutionen
- Microfluidics International Corporation, P.O. Box 9101, Newton, MA 02464, USA.
Zitieren
APA
Panagiotou, T., & Fisher, R. J. (2011). Enhanced Transport Capabilities via Nanotechnologies: Impacting Bioefficacy, Controlled Release Strategies, and Novel Chaperones. Journal of Drug Delivery, 2011, 1-14. https://doi.org/10.1155/2011/902403
Vancouver
Panagiotou T, Fisher RJ. Enhanced Transport Capabilities via Nanotechnologies: Impacting Bioefficacy, Controlled Release Strategies, and Novel Chaperones. Journal of Drug Delivery. 2011;2011:1-14. doi:10.1155/2011/902403
BibTeX
@article{Panagiotou2011,
author = {Panagiotou, Thomai and Fisher, Robert J},
title = {Enhanced Transport Capabilities via Nanotechnologies: Impacting Bioefficacy, Controlled Release Strategies, and Novel Chaperones},
journal = {Journal of Drug Delivery},
year = {2011},
volume = {2011},
pages = {1--14},
doi = {10.1155/2011/902403}
}
EUVIMED